Great Lakes Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,740
Closed -$1.7M 826
2024
Q4
$1.7M Sell
21,740
-1,092
-5% -$87.7K 0.01% 497
2024
Q3
$1.84M Sell
22,832
-136,508
-86% -$11M 0.02% 496
2024
Q2
$13.2M Sell
159,340
-8,210
-5% -$722K 0.12% 167
2024
Q1
$14.3M Sell
167,550
-1,705
-1% -$134K 0.12% 167
2023
Q4
$14.5M Sell
169,255
-28,168
-14% -$2.44M 0.14% 162
2023
Q3
$17.7M Buy
197,423
+17,560
+10% +$1.57M 0.16% 132
2023
Q2
$15.3M Buy
179,863
+16,569
+10% +$1.4M 0.15% 153
2023
Q1
$13.5M Buy
163,294
+143,942
+744% +$11.7M 0.12% 156
2022
Q4
$1.52M Sell
19,352
-8,651
-31% -$695K 0.09% 338
2022
Q3
$2.07M Sell
28,003
-252
-0.9% -$18.1K 0.05% 343
2022
Q2
$1.84M Buy
28,255
+2,931
+12% +$173K 0.04% 375
2022
Q1
$1.6M Sell
25,324
-2,838
-10% -$154K 0.03% 405
2021
Q4
$1.49M Sell
28,162
-1,387
-5% -$84.5K 0.02% 411
2021
Q3
$2.09M Buy
+29,549
New +$1.86M 0.03% 374

Other funds holding HAE